AU3212897A - Anti-viral compounds - Google Patents

Anti-viral compounds

Info

Publication number
AU3212897A
AU3212897A AU32128/97A AU3212897A AU3212897A AU 3212897 A AU3212897 A AU 3212897A AU 32128/97 A AU32128/97 A AU 32128/97A AU 3212897 A AU3212897 A AU 3212897A AU 3212897 A AU3212897 A AU 3212897A
Authority
AU
Australia
Prior art keywords
viral compounds
viral
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32128/97A
Inventor
Louis N Jungheim
Timothy A Shepherd
Wayne A. Spitzer
Mark J. Tebbe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU3212897A publication Critical patent/AU3212897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU32128/97A 1996-06-05 1997-06-05 Anti-viral compounds Abandoned AU3212897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1917096P 1996-06-05 1996-06-05
US60019170 1996-06-05
PCT/US1997/008848 WO1997046237A1 (en) 1996-06-05 1997-06-05 Anti-viral compounds

Publications (1)

Publication Number Publication Date
AU3212897A true AU3212897A (en) 1998-01-05

Family

ID=21791797

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32128/97A Abandoned AU3212897A (en) 1996-06-05 1997-06-05 Anti-viral compounds

Country Status (9)

Country Link
EP (1) EP0906097A4 (en)
JP (1) JP2000511899A (en)
KR (1) KR20000016346A (en)
CN (1) CN1220601A (en)
AU (1) AU3212897A (en)
BR (1) BR9709528A (en)
CA (1) CA2257296A1 (en)
EA (1) EA001316B1 (en)
WO (1) WO1997046237A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
WO1998031363A1 (en) * 1997-01-22 1998-07-23 Eli Lilly And Company Anti-viral compounds
CA2293508A1 (en) * 1997-06-04 1998-12-10 Louis Nickolaus Jungheim Anti-viral compounds
SK17482000A3 (en) * 1998-05-20 2005-03-04 Eli Lilly And Company Antiviral compounds, method for inhibiting viruses and pharmaceutical composition
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
CZ20013424A3 (en) * 1999-12-27 2002-02-13 Japan Tobacco Inc. Compounds with fused rings and their use as medicaments
CA2534649A1 (en) 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
JP4143669B2 (en) 2004-02-24 2008-09-03 日本たばこ産業株式会社 Four-ring condensed heterocyclic compounds and their use as HCV polymerase inhibitors
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420479A (en) * 1982-04-08 1983-12-13 Eli Lilly And Company Olefinic benzimidazoles, formulations, and antiviral methods
US4434288A (en) * 1982-04-08 1984-02-28 Eli Lilly And Company Preparation of substituted 1-thiazinyl or 1-thiazolyl-2-aminobenzimidazoles
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles

Also Published As

Publication number Publication date
EP0906097A1 (en) 1999-04-07
CN1220601A (en) 1999-06-23
EP0906097A4 (en) 2000-12-13
EA199801078A1 (en) 1999-04-29
CA2257296A1 (en) 1997-12-11
JP2000511899A (en) 2000-09-12
BR9709528A (en) 1999-08-10
EA001316B1 (en) 2001-02-26
KR20000016346A (en) 2000-03-25
WO1997046237A1 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
AU3212797A (en) Anti-viral compounds
AU5703398A (en) Novel compounds
AU6804098A (en) Triazinylaminostilbene compounds
AU3057697A (en) Anti-viral compounds
AU4925697A (en) Compounds
AU5982496A (en) Anti-viral compounds
AU2752597A (en) Anti-viral compounds
AU3286297A (en) Anti-viral compounds
AU7715198A (en) Anti-viral compounds
AU3620297A (en) Substituted triazoloazinesulphonamides
AU3212897A (en) Anti-viral compounds
AUPP042397A0 (en) 5-arylpyrazole compounds
AU7124598A (en) Polymer-platinum compounds
AU5423298A (en) Novel compounds
AU3771497A (en) Substituted p-trifluoromethylphenyluracils
AU6031898A (en) Anti-viral compounds
AU6042096A (en) Anti-viral compounds
AUPO062696A0 (en) Novel compounds
AU1926397A (en) Substituted 1-methyl-3-benzyluracils
AU8137594A (en) Anti-viral guanidino-substituted compounds
AU1900097A (en) Cremators
AU3711697A (en) Novel compounds
AU8019998A (en) Fluoromethoximino compounds
AU5983798A (en) Heterocyclyluracils
AU2955597A (en) Substituted phenyluracils